Key Findings
The North America region contributed $XX million in 2018 and is projected to reach $XX million by 2027, registering a CAGR of 4.13% through the forecasting years of 2019-2027.

Market Insights
North America ophthalmic laser market find its applications primarily in the treatment of various ophthalmic diseases such as cataract, glaucoma, AMD, etc. North America ophthalmic laser market is expected to be on up-surging trend owing to the rising number of studies based on ophthalmology disease, various grants and funding to support ophthalmology research and high prevalence of diabetes in a region.

Competitive Insights
In March 2017, the U.S.-based company, Iridex Corporation, had launched the G-Probe Illuminate at American Glaucoma Society that can be used for office-based procedures or in the operating room and has an inbuilt transillumination feature that would allow visualization of the ciliary body and successive targeted trans-scleral cyclophotocoagulation.